🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 158 of 200 · A–Z by INN

  1. repaglinide

    REPAGLINIDE SUN Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    A10BX02

  2. repository corticotropin

    H.P. ACTHAR GEL

    INJECTION FDA: approved

  3. repotrectinib

    AUGTYRO

    ORAL FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    L01EX28

  4. rescinnamine

    CINNASIL

    ORAL FDA: approved

  5. reserpine

    RESERPINE BICYCLE THERAPEUTICS

    INJECTION FDA: approved

  6. reslizumab

    CINQAERO Teva Pharma GmbH

    INJECTION FDA: approved · EMA: approved

    R03DX08

  7. resmetirom

    REZDIFFRA Madrigal Pharmaceuticals EU Limited

    ORAL FDA: approved · EMA: approved

    A05

  8. resminostat

    KINSELBY

    EMA: unknown

    L01X

  9. resorcinol

    NULL

    TGA: approved

  10. respiratory syncytial virus mrna vaccine

    MRESVIA Teva Pharma GmbH

    EMA: approved

    J07BX05

  11. respiratory syncytial virus rna vaccine

    MRESVIA

    PMDA: approved

  12. respiratory syncytial virus vaccine (bivalent, recombinant)

    ABRYSVO

    EMA: approved

    J07BX05

  13. retapamulin

    ALTARGO Almirall, S.A.

    TOPICAL FDA: approved · EMA: withdrawn

    D06AX13

  14. reteplase

    ECOKINASE

    FDA: approved · EMA: withdrawn

    B01AD07

  15. retifanlimab

    ZYNYZ

    EMA: approved

    L01FF10

  16. retifanlimab-dlwr

    ZYNYZ

    INTRAVENOUS FDA: approved

  17. retigabine

    TROBALT

    EMA: withdrawn

    N03AX21

  18. reuteri

    NMPA: clinical trials

  19. revefenacin

    REVEFENACIN

    INHALATION FDA: approved · NMPA: clinical trials

  20. revumenib citrate

    REVUFORJ Syndax Pharmaceuticals

    ORAL FDA: approved

  21. rezafungin

    REZZAYO

    EMA: approved

    J02AX08

  22. rezafungin acetate

    REZZAYO

    INTRAVENOUS FDA: approved

  23. rezvilutamide

    NMPA: clinical trials

  24. rhg-csf

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources